查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1516926

自訂抗體的全球市場的評估:各類型，各類服務，來歷，各研究領域，各用途，各終端用戶，各地區，機會，預測，2017年～2031年

Custom Antibody Market Assessment, By Type, By Service, By Source, By Research Area, By Application, By End-users, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 230 Pages | 商品交期: 3-5個工作天內

價格

根據預測，全球客製化抗體市場規模將從2023年的4.5188億美元成長到2031年的9.3625億美元，在2024-2031年的預測期內複合年增長率為9.53%。各種慢性病病例數量的增加、精準醫療需求的增加以及研發活動的增加推動了市場成長。

傳染病、自體免疫疾病和癌症病例的增加正在推動全球客製化抗體市場的規模擴大。單株和多株抗體對多種抗原具有親和力，使其可用於這些疾病的管理、治療和診斷。生物化學家和研究人員使用多克隆抗體來分析生物樣本，從而推動市場需求。醫療保健行業的快速擴張也支持了市場的成長，因為客製化抗體使研究人員能夠確定各種疫苗和療法的有效性，從而在臨床研究中發揮重要作用。

公司增加擴大生產設施的投資也是支持市場成長的主要因素。 2022 年 8 月，重組服務和產品的領先供應商之一 Absolute Antibody Ltd 宣布擴建其位於英格蘭東北部的製造工廠。透過此次擴張，該公司預計將為客戶提供增強的服務並支持其重組抗體產品組合的擴張。該公司的客製化抗體表現、定序和工程服務被世界各地的各種診斷、生物技術和製藥公司以及學術機構使用。這種類型的業務擴張預計將有助於擴大公司的影響力並支持市場擴張。

依本報告提供全球自訂抗體市場相關調查，提供市場概要，以及各類型，各類服務，來歷，各研究領域，各用途，各終端用戶，各地區趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 調查手法

第2章 計劃的範圍和定義

第3章 摘要整理

第4章 全球自訂抗體市場預測，2017年～2031年

  • 市場規模與預測
  • 各類型
  • 各類服務
  • 各來歷
  • 各研究領域
  • 各用途
  • 各終端用戶
  • 各地區
  • 各企業市場佔有率(%)、2023年

第5章 自訂抗體市場預測，各地區(2017年～2031年)

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第6章 市場製圖，2023年

第7章 宏觀環境和產業結構

  • 供給需求分析
  • 進出口分析
  • 價值鏈分析
  • PESTEL分析
  • 波特的五力分析

第8章 市場動態

第9章 法規結構和革新

第10章 主要加入企業的形勢

第11章 價格分析

第12章 案例研究

第13章 主要加入企業預測

  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • BioLegend, Inc.
  • GenScript Biotech Corporation
  • RayBiotech, Inc.
  • Cell Signaling Technology, Inc.
  • ProMab Biotechnologies, Inc.
  • Sino Biological, Inc.

第14章 策略性建議

第15章 諮詢方式和免責聲明

Product Code: MX11610

Global custom antibody market is projected to witness a CAGR of 9.53% during the forecast period 2024-2031F, growing from USD 451.88 million in 2023 to USD 936.25 million in 2031F. The growth of the market is bolstered by increasing cases of various chronic conditions, rising requirement for precision medicine, and increasing research and development activities.

The rising cases of infectious and autoimmune diseases, and cancer are bolstering the global custom antibody market size. Monoclonal and polyclonal antibodies aid in managing, treating, and diagnosing such diseases due to their affinity for multiple antigens. Biochemists and researchers use polyclonal antibodies to analyze biological samples, thus propelling the market demand. The rapid expansion of the healthcare sector is also supporting the growth of the market as custom antibodies play a vital role in clinical research by allowing the researchers to determine the effectiveness of different vaccines and therapeutics.

The increasing investments by companies towards the expansion of their manufacturing facilities is another major factor supporting the growth of the market. In August 2022, Absolute Antibody Ltd, one of the leading providers of recombinant services and products, announced the expansion of its manufacturing facility in northeast England. This expansion is expected to aid the company in providing enhanced services to its customers and support the expansion of its recombinant antibody portfolio. The company's custom antibody expression, sequencing, and engineering services are utilized by various diagnostic, biotechnology, and pharmaceutical companies and academic institutes across the globe. Such expansions are expected to aid the companies in expanding their presence and support the market's expansion. Additionally, various market players are also investing in acquisitions to enhance their global presence. For instance, in April 2024, Sino Biological, Inc. announced the accusation of SignalChem Biotech Inc. in a USD 48 million deal. The latter's acquisition will aid Sino in boosting its presence in bioactive recombinant proteins contract research services.

Rising Investments Towards Research and Development Supports Market Expansion

The growing investments by various biotechnology companies in research and development activities are expected to positively influence the growth of the market in the coming years. In October 2022, Taconic Biosciences, Inc. launched the first super immunodeficient mouse model that lacks residual murine Fc gamma receptors. The FcResolv NOG models provide enhanced clarity in antibody-based drug studies, ensuring the availability of more transferable data with fewer animals and studies. The model is viable for engrafting a diverse range of tissues and human cells and has applications in autoimmune diseases, immune-oncology, and oncology. The NOG portfolio provided by the company will aid researchers in evaluating drug candidates without interference from residual murine Fc gamma receptors and eliminate false negatives. The portfolio also eliminates the deconvolution steps required for distinguishing the efficacy of the drugs from the mouse immune system-mediated off-target effects, allowing researchers to use drug discovery investments in an effective manner.

Increasing Requirement for Precision Medicine Supports Market Growth

The increasing popularity of precision medicine in different regions across the globe can be attributed to their ability to consider the variability in the lifestyle, environment, and genes of every individual. This treatment strategy ensures that preventive and therapeutic interventions are provided to patients that aid in reducing costs and maximize health benefits and span across a broad range of arenas that include casual inference, genetics and genomics, health communication, and drug discovery. The antibody-based precision medicines use monoclonal antibodies for targeting disease-causing molecules. Monoclonal antibodies can provide effective and targeted therapies that have fewer side effects in comparison to the traditional treatment options because they target specific molecules that are involved with the progression or development of the disease. Additionally, precision medicine also plays a crucial role in autoimmune disorders that demonstrate both molecular and clinical variability. According to the estimates from the Johns Hopkins Medicine, autoimmune diseases affect approximately 3% of the population of the United States. Thus, the increasing prevalence of such diseases is further providing lucrative growth opportunities to the market.

North America Accounts for Significant Market Share

The market's expansion in the region can be attributed to the strong presence of key market players, expansion of the healthcare and pharmaceutical sectors, and the increasing investments in research and development activities. The rapid growth of the biotechnology sector in the region due to rising research activities in the biopharmaceutical sector and increasing prevalence of chronic diseases is also providing lucrative growth opportunities to the market. According to the estimates of the Canadian Cancer Society, in 2024, approximately 247,100 new cases and 88,100 deaths related to cancer are expected to occur in Canada.

Furthermore, the increasing investments by leading market players in the region are also providing lucrative growth opportunities for the market. In October 2023, Sino Biological, Inc. announced the opening of their new center for Bioprocessing in Houston, United States, adjacent to the renowned Texas Medical Center. The center is going to specialize in contract research services, including recombinant antibody and recombinant protein manufacture and development. The center will also focus on the production and development of diagnostic and research grade proteins and antibodies by using mammalian cells and will aid the biotechnology company in expanding their global presence.

Oncology Expected to Witness Significant Growth

The rising prevalence of cancer in various regions across the globe is propelling the demand for custom antibodies in the global market. As per the estimates of the American Cancer Society, approximately 2,001,140 new cases and 611,720 deaths are expected to occur because of cancer in 2024. Monoclonal custom antibodies are capable of causing the death of tumor cells via a wide range of mechanisms. The direct mechanism involves blocking the growth factor receptor signaling to induce tumor cell death. In various types of cancer, the overexpression of epidermal growth factor receptor (EGFR) occurs, which results in the proliferation of tumor cells. With the help of an anti-EGFR monoclonal antibody, the dimerization of the receptor occurs, which blocks ligand binding, leading to the apoptosis of tumor cells.

Future Market Scenario (2024-2031F)

According to the global custom antibody market analysis, the rising cases of cancer, infectious diseases, autoimmune diseases, and cardiovascular diseases over the coming years in different regions across the globe are expected to provide lucrative growth opportunities to the market. Custom antibodies are also expected to aid in improving the accuracy of various diagnostic tests, allowing for early detection of diseases while aiding in the development of novel therapies. Over the forecast period, they are expected to play a pivotal role in the study of specific cellular processes and pathways and support the development of personalized medicines for targeting specific diseases.

Key Players Landscape and Outlook

The rising investments by leading market players towards service partnerships are boosting the global custom antibody market growth. In April 2024, Sino Biological, Inc., known for providing biological research agents, announced a service partnership with Rapid Novor, Inc. The former is going to market Rapid's proprietary REmAb monoclonal antibody sequencing services in South Korea, China, Japan, Vietnam, Philippines, Indonesia, Malaysia, Thailand, and Singapore. With this partnership, Sino's clients will have access to accurate sequencing with the help of Rapid's REmAb technology. Such partnerships are expected to aid market players in expanding their customer base and ensure the provision of advanced technological solutions.

Table of Contents

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Custom Antibody Market Outlook, 2017-2031F

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
  • 4.2. By Type
    • 4.2.1. Monoclonal Antibodies
    • 4.2.2. Polyclonal Antibodies
    • 4.2.3. Recombinant Antibodies
    • 4.2.4. Others
  • 4.3. By Service
    • 4.3.1. Antibody Development
      • 4.3.1.1. Antigen Preparation
      • 4.3.1.2. Antibody Characterization
      • 4.3.1.3. Immunization and Hybridoma Production
    • 4.3.2. Antibody Production and Purification
    • 4.3.3. Antibody Fragmentation and Labeling
  • 4.4. By Source
    • 4.4.1. Mice
    • 4.4.2. Rabbits
    • 4.4.3. Others
  • 4.5. By Research Area
    • 4.5.1. Immunology
    • 4.5.2. Neurobiology
    • 4.5.3. Oncology
    • 4.5.4. Infectious Diseases
    • 4.5.5. Cardiovascular Diseases
    • 4.5.6. Others
  • 4.6. By Application
    • 4.6.1. Therapeutics
    • 4.6.2. Research
  • 4.7. By End-users
    • 4.7.1. Pharmaceutical and Biotechnology Companies
    • 4.7.2. Contract Research Organizations
    • 4.7.3. Research and Academic Institutions
  • 4.8. By Region
    • 4.8.1. North America
    • 4.8.2. South America
    • 4.8.3. Europe
    • 4.8.4. Asia-Pacific
    • 4.8.5. Middle East and Africa
  • 4.9. By Company Market Share (%), 2023

5. Global Custom Antibody Market Outlook, By Region, 2017-2031F

  • 5.1. North America*
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. By Value
    • 5.1.2. By Type
      • 5.1.2.1. Monoclonal Antibodies
      • 5.1.2.2. Polyclonal Antibodies
      • 5.1.2.3. Recombinant Antibodies
      • 5.1.2.4. Others
    • 5.1.3. By Service
      • 5.1.3.1. Antibody Development
        • 5.1.3.1.1. Antigen Preparation
        • 5.1.3.1.2. Antibody Characterization
        • 5.1.3.1.3. Immunization and Hybridoma Production
      • 5.1.3.2. Antibody Production and Purification
      • 5.1.3.3. Antibody Fragmentation and Labeling
    • 5.1.4. By Source
      • 5.1.4.1. Mice
      • 5.1.4.2. Rabbits
      • 5.1.4.3. Others
    • 5.1.5. By Research Area
      • 5.1.5.1. Immunology
      • 5.1.5.2. Neurobiology
      • 5.1.5.3. Oncology
      • 5.1.5.4. Infectious Diseases
      • 5.1.5.5. Cardiovascular Diseases
      • 5.1.5.6. Others
    • 5.1.6. By Application
      • 5.1.6.1. Therapeutics
      • 5.1.6.2. Research
    • 5.1.7. By End-users
      • 5.1.7.1. Pharmaceutical and Biotechnology Companies
      • 5.1.7.2. Contract Research Organizations
      • 5.1.7.3. Research and Academic Institutions
    • 5.1.8. United States*
      • 5.1.8.1. Market Size & Forecast
        • 5.1.8.1.1. By Value
      • 5.1.8.2. By Type
        • 5.1.8.2.1. Monoclonal Antibodies
        • 5.1.8.2.2. Polyclonal Antibodies
        • 5.1.8.2.3. Recombinant Antibodies
        • 5.1.8.2.4. Others
      • 5.1.8.3. By Service
        • 5.1.8.3.1. Antibody Development
          • 5.1.8.3.1.1. Antigen Preparation
          • 5.1.8.3.1.2. Antibody Characterization
          • 5.1.8.3.1.3. Immunization and Hybridoma Production
        • 5.1.8.3.2. Antibody Production and Purification
        • 5.1.8.3.3. Antibody Fragmentation and Labeling
      • 5.1.8.4. By Source
        • 5.1.8.4.1. Mice
        • 5.1.8.4.2. Rabbits
        • 5.1.8.4.3. Others
      • 5.1.8.5. By Research Area
        • 5.1.8.5.1. Immunology
        • 5.1.8.5.2. Neurobiology
        • 5.1.8.5.3. Oncology
        • 5.1.8.5.4. Infectious Diseases
        • 5.1.8.5.5. Cardiovascular Diseases
        • 5.1.8.5.6. Others
      • 5.1.8.6. By Application
        • 5.1.8.6.1. Therapeutics
        • 5.1.8.6.2. Research
      • 5.1.8.7. By End-users
        • 5.1.8.7.1. Pharmaceutical and Biotechnology Companies
        • 5.1.8.7.2. Contract Research Organizations
        • 5.1.8.7.3. Research and Academic Institutions
    • 5.1.9. Canada
    • 5.1.10. Mexico

All segments will be provided for all regions and countries covered

  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. Italy
    • 5.2.4. United Kingdom
    • 5.2.5. Russia
    • 5.2.6. Netherlands
    • 5.2.7. Spain
    • 5.2.8. Turkey
    • 5.2.9. Poland
  • 5.3. Asia-Pacific
    • 5.3.1. India
    • 5.3.2. China
    • 5.3.3. Japan
    • 5.3.4. Australia
    • 5.3.5. Vietnam
    • 5.3.6. South Korea
    • 5.3.7. Indonesia
    • 5.3.8. Philippines
  • 5.4. South America
    • 5.4.1. Brazil
    • 5.4.2. Argentina
  • 5.5. Middle East and Africa
    • 5.5.1. Saudi Arabia
    • 5.5.2. UAE
    • 5.5.3. South Africa

6. Market Mapping, 2023

  • 6.1. By Type
  • 6.2. By Service
  • 6.3. By Source
  • 6.4. By Research Area
  • 6.5. By Application
  • 6.6. By End-users
  • 6.7. By Region

7. Macro Environment and Industry Structure

  • 7.1. Supply Demand Analysis
  • 7.2. Import Export Analysis
  • 7.3. Value Chain Analysis
  • 7.4. PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5. Porter's Five Forces Analysis
    • 7.5.1. Supplier Power
    • 7.5.2. Buyer Power
    • 7.5.3. Substitution Threat
    • 7.5.4. Threat From New Entrant
    • 7.5.5. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

  • 9.1. Patent Landscape
  • 9.2. Regulatory Approvals
  • 9.3. Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (By Value, 2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)
  • 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

  • 13.1. Thermo Fisher Scientific Inc.
    • 13.1.1. Company Details
    • 13.1.2. Key Management Personnel
    • 13.1.3. Products and Services
    • 13.1.4. Financials (As Reported)
    • 13.1.5. Key Market Focus and Geographical Presence
    • 13.1.6. Recent Developments
  • 13.2. Bio-Rad Laboratories, Inc.
  • 13.3. Danaher Corporation
  • 13.4. Agilent Technologies, Inc.
  • 13.5. BioLegend, Inc.
  • 13.6. GenScript Biotech Corporation
  • 13.7. RayBiotech, Inc.
  • 13.8. Cell Signaling Technology, Inc.
  • 13.9. ProMab Biotechnologies, Inc.
  • 13.10. Sino Biological, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14. Strategic Recommendations

15. About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Custom Antibody Market, By Value, In USD Million, 2017-2031F
  • Figure 2. Global Custom Antibody Market Share (%), By Type, 2017-2031F
  • Figure 3. Global Custom Antibody Market Share (%), By Service, 2017-2031F
  • Figure 4. Global Custom Antibody Market Share (%), By Source, 2017-2031F
  • Figure 5. Global Custom Antibody Market Share (%), By Research Area, 2017-2031F
  • Figure 6. Global Custom Antibody Market Share (%), By Application, 2017-2031F
  • Figure 7. Global Custom Antibody Market Share (%), By End-users, 2017-2031F
  • Figure 8. Global Custom Antibody Market Share (%), By Region, 2017-2031F
  • Figure 9. North America Custom Antibody Market, By Value, In USD Million, 2017-2031F
  • Figure 10. North America Custom Antibody Market Share (%), By Type, 2017-2031F
  • Figure 11. North America Custom Antibody Market Share (%), By Service, 2017-2031F
  • Figure 12. North America Custom Antibody Market Share (%), By Source, 2017-2031F
  • Figure 13. North America Custom Antibody Market Share (%), By Research Area, 2017-2031F
  • Figure 14. North America Custom Antibody Market Share (%), By Application, 2017-2031F
  • Figure 15. North America Custom Antibody Market Share (%), By End-users, 2017-2031F
  • Figure 16. North America Custom Antibody Market Share (%), By Country, 2017-2031F
  • Figure 17. United States Custom Antibody Market, By Value, In USD Million, 2017-2031F
  • Figure 18. United States Custom Antibody Market Share (%), By Type, 2017-2031F
  • Figure 19. United States Custom Antibody Market Share (%), By Service, 2017-2031F
  • Figure 20. United States Custom Antibody Market Share (%), By Source, 2017-2031F
  • Figure 21. United States Custom Antibody Market Share (%), By Research Area, 2017-2031F
  • Figure 22. United States Custom Antibody Market Share (%), By Application, 2017-2031F
  • Figure 23. United States Custom Antibody Market Share (%), By End-users, 2017-2031F
  • Figure 24. Canada Custom Antibody Market, By Value, In USD Million, 2017-2031F
  • Figure 25. Canada Custom Antibody Market Share (%), By Type, 2017-2031F
  • Figure 26. Canada Custom Antibody Market Share (%), By Service, 2017-2031F
  • Figure 27. Canada Custom Antibody Market Share (%), By Source, 2017-2031F
  • Figure 28. Canada Custom Antibody Market Share (%), By Research Area, 2017-2031F
  • Figure 29. Canada Custom Antibody Market Share (%), By Application, 2017-2031F
  • Figure 30. Canada Custom Antibody Market Share (%), By End-users, 2017-2031F
  • Figure 31. Mexico Custom Antibody Market, By Value, In USD Million, 2017-2031F
  • Figure 32. Mexico Custom Antibody Market Share (%), By Type, 2017-2031F
  • Figure 33. Mexico Custom Antibody Market Share (%), By Service, 2017-2031F
  • Figure 34. Mexico Custom Antibody Market Share (%), By Source, 2017-2031F
  • Figure 35. Mexico Custom Antibody Market Share (%), By Research Area, 2017-2031F
  • Figure 36. Mexico Custom Antibody Market Share (%), By Application, 2017-2031F
  • Figure 37. Mexico Custom Antibody Market Share (%), By End-users, 2017-2031F
  • Figure 38. Europe Custom Antibody Market, By Value, In USD Million, 2017-2031F
  • Figure 39. Europe Custom Antibody Market Share (%), By Type, 2017-2031F
  • Figure 40. Europe Custom Antibody Market Share (%), By Service, 2017-2031F
  • Figure 41. Europe Custom Antibody Market Share (%), By Source, 2017-2031F
  • Figure 42. Europe Custom Antibody Market Share (%), By Research Area, 2017-2031F
  • Figure 43. Europe Custom Antibody Market Share (%), By Application, 2017-2031F
  • Figure 44. Europe Custom Antibody Market Share (%), By End-users, 2017-2031F
  • Figure 45. Europe Custom Antibody Market Share (%), By Country, 2017-2031F
  • Figure 46. Germany Custom Antibody Market, By Value, In USD Million, 2017-2031F
  • Figure 47. Germany Custom Antibody Market Share (%), By Type, 2017-2031F
  • Figure 48. Germany Custom Antibody Market Share (%), By Service, 2017-2031F
  • Figure 49. Germany Custom Antibody Market Share (%), By Source, 2017-2031F
  • Figure 50. Germany Custom Antibody Market Share (%), By Research Area, 2017-2031F
  • Figure 51. Germany Custom Antibody Market Share (%), By Application, 2017-2031F
  • Figure 52. Germany Custom Antibody Market Share (%), By End-users, 2017-2031F
  • Figure 53. France Custom Antibody Market, By Value, In USD Million, 2017-2031F
  • Figure 54. France Custom Antibody Market Share (%), By Type, 2017-2031F
  • Figure 55. France Custom Antibody Market Share (%), By Service, 2017-2031F
  • Figure 56. France Custom Antibody Market Share (%), By Source, 2017-2031F
  • Figure 57. France Custom Antibody Market Share (%), By Research Area, 2017-2031F
  • Figure 58. France Custom Antibody Market Share (%), By Application, 2017-2031F
  • Figure 59. France Custom Antibody Market Share (%), By End-users, 2017-2031F
  • Figure 60. Italy Custom Antibody Market, By Value, In USD Million, 2017-2031F
  • Figure 61. Italy Custom Antibody Market Share (%), By Type, 2017-2031F
  • Figure 62. Italy Custom Antibody Market Share (%), By Service, 2017-2031F
  • Figure 63. Italy Custom Antibody Market Share (%), By Source, 2017-2031F
  • Figure 64. Italy Custom Antibody Market Share (%), By Research Area, 2017-2031F
  • Figure 65. Italy Custom Antibody Market Share (%), By Application, 2017-2031F
  • Figure 66. Italy Custom Antibody Market Share (%), By End-users, 2017-2031F
  • Figure 67. United Kingdom Custom Antibody Market, By Value, In USD Million, 2017-2031F
  • Figure 68. United Kingdom Custom Antibody Market Share (%), By Type, 2017-2031F
  • Figure 69. United Kingdom Custom Antibody Market Share (%), By Service, 2017-2031F
  • Figure 70. United Kingdom Custom Antibody Market Share (%), By Source, 2017-2031F
  • Figure 71. United Kingdom Custom Antibody Market Share (%), By Research Area, 2017-2031F
  • Figure 72. United Kingdom Custom Antibody Market Share (%), By Application, 2017-2031F
  • Figure 73. United Kingdom Custom Antibody Market Share (%), By End-users, 2017-2031F
  • Figure 74. Russia Custom Antibody Market, By Value, In USD Million, 2017-2031F
  • Figure 75. Russia Custom Antibody Market Share (%), By Type, 2017-2031F
  • Figure 76. Russia Custom Antibody Market Share (%), By Service, 2017-2031F
  • Figure 77. Russia Custom Antibody Market Share (%), By Source, 2017-2031F
  • Figure 78. Russia Custom Antibody Market Share (%), By Research Area, 2017-2031F
  • Figure 79. Russia Custom Antibody Market Share (%), By Application, 2017-2031F
  • Figure 80.
  • Figure 81. Russia Custom Antibody Market Share (%), By End-users, 2017-2031F
  • Figure 82. Netherlands Custom Antibody Market, By Value, In USD Million, 2017-2031F
  • Figure 83. Netherlands Custom Antibody Market Share (%), By Type, 2017-2031F
  • Figure 84. Netherlands Custom Antibody Market Share (%), By Service, 2017-2031F
  • Figure 85. Netherlands Custom Antibody Market Share (%), By Source, 2017-2031F
  • Figure 86. Netherlands Custom Antibody Market Share (%), By Research Area, 2017-2031F
  • Figure 87. Netherlands Custom Antibody Market Share (%), By Application, 2017-2031F
  • Figure 88. Netherlands Custom Antibody Market Share (%), By End-users, 2017-2031F
  • Figure 89. Spain Custom Antibody Market, By Value, In USD Million, 2017-2031F
  • Figure 90. Spain Custom Antibody Market Share (%), By Type, 2017-2031F
  • Figure 91. Spain Custom Antibody Market Share (%), By Service, 2017-2031F
  • Figure 92. Spain Custom Antibody Market Share (%), By Source, 2017-2031F
  • Figure 93. Spain Custom Antibody Market Share (%), By Research Area, 2017-2031F
  • Figure 94. Spain Custom Antibody Market Share (%), By Application, 2017-2031F
  • Figure 95. Spain Custom Antibody Market Share (%), By End-users, 2017-2031F
  • Figure 96. Turkey Custom Antibody Market, By Value, In USD Million, 2017-2031F
  • Figure 97. Turkey Custom Antibody Market Share (%), By Type, 2017-2031F
  • Figure 98. Turkey Custom Antibody Market Share (%), By Service, 2017-2031F
  • Figure 99. Turkey Custom Antibody Market Share (%), By Source, 2017-2031F
  • Figure 100. Turkey Custom Antibody Market Share (%), By Research Area, 2017-2031F
  • Figure 101. Turkey Custom Antibody Market Share (%), By Application, 2017-2031F
  • Figure 102. Turkey Custom Antibody Market Share (%), By End-users, 2017-2031F
  • Figure 103. Poland Custom Antibody Market, By Value, In USD Million, 2017-2031F
  • Figure 104. Poland Custom Antibody Market Share (%), By Type, 2017-2031F
  • Figure 105. Poland Custom Antibody Market Share (%), By Service, 2017-2031F
  • Figure 106. Poland Custom Antibody Market Share (%), By Source, 2017-2031F
  • Figure 107. Poland Custom Antibody Market Share (%), By Research Area, 2017-2031F
  • Figure 108. Poland Custom Antibody Market Share (%), By Application, 2017-2031F
  • Figure 109. Poland Custom Antibody Market Share (%), By End-users, 2017-2031F
  • Figure 110. South America Custom Antibody Market, By Value, In USD Million, 2017-2031F
  • Figure 111. South America Custom Antibody Market Share (%), By Type, 2017-2031F
  • Figure 112. South America Custom Antibody Market Share (%), By Service, 2017-2031F
  • Figure 113. South America Custom Antibody Market Share (%), By Source, 2017-2031F
  • Figure 114. South America Custom Antibody Market Share (%), By Research Area, 2017-2031F
  • Figure 115. South America Custom Antibody Market Share (%), By Application, 2017-2031F
  • Figure 116. South America Custom Antibody Market Share (%), By End-users, 2017-2031F
  • Figure 117. South America Custom Antibody Market Share (%), By Country, 2017-2031F
  • Figure 118. Brazil Custom Antibody Market, By Value, In USD Million, 2017-2031F
  • Figure 119. Brazil Custom Antibody Market Share (%), By Type, 2017-2031F
  • Figure 120. Brazil Custom Antibody Market Share (%), By Service, 2017-2031F
  • Figure 121. Brazil Custom Antibody Market Share (%), By Source, 2017-2031F
  • Figure 122. Brazil Custom Antibody Market Share (%), By Research Area, 2017-2031F
  • Figure 123. Brazil Custom Antibody Market Share (%), By Application, 2017-2031F
  • Figure 124. Brazil Custom Antibody Market Share (%), By End-users, 2017-2031F
  • Figure 125. Argentina Custom Antibody Market, By Value, In USD Million, 2017-2031F
  • Figure 126. Argentina Custom Antibody Market Share (%), By Type, 2017-2031F
  • Figure 127. Argentina Custom Antibody Market Share (%), By Service, 2017-2031F
  • Figure 128. Argentina Custom Antibody Market Share (%), By Source, 2017-2031F
  • Figure 129. Argentina Custom Antibody Market Share (%), By Research Area, 2017-2031F
  • Figure 130. Argentina Custom Antibody Market Share (%), By Application, 2017-2031F
  • Figure 131. Argentina Custom Antibody Market Share (%), By End-users, 2017-2031F
  • Figure 132. Asia-Pacific Custom Antibody Market, By Value, In USD Million, 2017-2031F
  • Figure 133. Asia-Pacific Custom Antibody Market Share (%), By Type, 2017-2031F
  • Figure 134. Asia-Pacific Custom Antibody Market Share (%), By Service, 2017-2031F
  • Figure 135. Asia-Pacific Custom Antibody Market Share (%), By Source, 2017-2031F
  • Figure 136. Asia-Pacific Custom Antibody Market Share (%), By Research Area, 2017-2031F
  • Figure 137. Asia-Pacific Custom Antibody Market Share (%), By Application, 2017-2031F
  • Figure 138. Asia-Pacific Custom Antibody Market Share (%), By End-users, 2017-2031F
  • Figure 139. Asia-Pacific Custom Antibody Market Share (%), By Country, 2017-2031F
  • Figure 140. India Custom Antibody Market, By Value, In USD Million, 2017-2031F
  • Figure 141. India Custom Antibody Market Share (%), By Type, 2017-2031F
  • Figure 142. India Custom Antibody Market Share (%), By Service, 2017-2031F
  • Figure 143. India Custom Antibody Market Share (%), By Source, 2017-2031F
  • Figure 144. India Custom Antibody Market Share (%), By Research Area, 2017-2031F
  • Figure 145. India Custom Antibody Market Share (%), By Application, 2017-2031F
  • Figure 146. India Custom Antibody Market Share (%), By End-users, 2017-2031F
  • Figure 147. China Custom Antibody Market, By Value, In USD Million, 2017-2031F
  • Figure 148. China Custom Antibody Market Share (%), By Type, 2017-2031F
  • Figure 149. China Custom Antibody Market Share (%), By Service, 2017-2031F
  • Figure 150. China Custom Antibody Market Share (%), By Source, 2017-2031F
  • Figure 151. China Custom Antibody Market Share (%), By Research Area, 2017-2031F
  • Figure 152. China Custom Antibody Market Share (%), By Application, 2017-2031F
  • Figure 153. China Custom Antibody Market Share (%), By End-users, 2017-2031F
  • Figure 154. Japan Custom Antibody Market, By Value, In USD Million, 2017-2031F
  • Figure 155. Japan Custom Antibody Market Share (%), By Type, 2017-2031F
  • Figure 156. Japan Custom Antibody Market Share (%), By Service, 2017-2031F
  • Figure 157. Japan Custom Antibody Market Share (%), By Source, 2017-2031F
  • Figure 158. Japan Custom Antibody Market Share (%), By Research Area, 2017-2031F
  • Figure 159. Japan Custom Antibody Market Share (%), By Application, 2017-2031F
  • Figure 160. Japan Custom Antibody Market Share (%), By End-users, 2017-2031F
  • Figure 161. Australia Custom Antibody Market, By Value, In USD Million, 2017-2031F
  • Figure 162. Australia Custom Antibody Market Share (%), By Type, 2017-2031F
  • Figure 163. Australia Custom Antibody Market Share (%), By Service, 2017-2031F
  • Figure 164. Australia Custom Antibody Market Share (%), By Source, 2017-2031F
  • Figure 165. Australia Custom Antibody Market Share (%), By Research Area, 2017-2031F
  • Figure 166. Australia Custom Antibody Market Share (%), By Application, 2017-2031F
  • Figure 167. Australia Custom Antibody Market Share (%), By End-users, 2017-2031F
  • Figure 168. Vietnam Custom Antibody Market, By Value, In USD Million, 2017-2031F
  • Figure 169. Vietnam Custom Antibody Market Share (%), By Type, 2017-2031F
  • Figure 170. Vietnam Custom Antibody Market Share (%), By Service, 2017-2031F
  • Figure 171. Vietnam Custom Antibody Market Share (%), By Source, 2017-2031F
  • Figure 172. Vietnam Custom Antibody Market Share (%), By Research Area, 2017-2031F
  • Figure 173. Vietnam Custom Antibody Market Share (%), By Application, 2017-2031F
  • Figure 174. Vietnam Custom Antibody Market Share (%), By End-users, 2017-2031F
  • Figure 175. South Korea Custom Antibody Market, By Value, In USD Million, 2017-2031F
  • Figure 176. South Korea Custom Antibody Market Share (%), By Type, 2017-2031F
  • Figure 177. South Korea Custom Antibody Market Share (%), By Service, 2017-2031F
  • Figure 178. South Korea Custom Antibody Market Share (%), By Source, 2017-2031F
  • Figure 179. South Korea Custom Antibody Market Share (%), By Research Area, 2017-2031F
  • Figure 180. South Korea Custom Antibody Market Share (%), By Application, 2017-2031F
  • Figure 181. South Korea Custom Antibody Market Share (%), By End-users, 2017-2031F
  • Figure 182. Indonesia Custom Antibody Market, By Value, In USD Million, 2017-2031F
  • Figure 183. Indonesia Custom Antibody Market Share (%), By Type, 2017-2031F
  • Figure 184. Indonesia Custom Antibody Market Share (%), By Service, 2017-2031F
  • Figure 185. Indonesia Custom Antibody Market Share (%), By Source, 2017-2031F
  • Figure 186. Indonesia Custom Antibody Market Share (%), By Research Area, 2017-2031F
  • Figure 187. Indonesia Custom Antibody Market Share (%), By Application, 2017-2031F
  • Figure 188. Indonesia Custom Antibody Market Share (%), By End-users, 2017-2031F
  • Figure 189. Philippines Custom Antibody Market, By Value, In USD Million, 2017-2031F
  • Figure 190. Philippines Custom Antibody Market Share (%), By Type, 2017-2031F
  • Figure 191. Philippines Custom Antibody Market Share (%), By Service, 2017-2031F
  • Figure 192. Philippines Custom Antibody Market Share (%), By Source, 2017-2031F
  • Figure 193. Philippines Custom Antibody Market Share (%), By Research Area, 2017-2031F
  • Figure 194. Philippines Custom Antibody Market Share (%), By Application, 2017-2031F
  • Figure 195. Philippines Custom Antibody Market Share (%), By End-users, 2017-2031F
  • Figure 196. Middle East & Africa Custom Antibody Market, By Value, In USD Million, 2017-2031F
  • Figure 197. Middle East & Africa Custom Antibody Market Share (%), By Type, 2017-2031F
  • Figure 198. Middle East & Africa Custom Antibody Market Share (%), By Service, 2017-2031F
  • Figure 199. Middle East & Africa Custom Antibody Market Share (%), By Source, 2017-2031F
  • Figure 200. Middle East & Africa Custom Antibody Market Share (%), By Research Area, 2017-2031F
  • Figure 201. Middle East & Africa Custom Antibody Market Share (%), By Application, 2017-2031F
  • Figure 202. Middle East & Africa Custom Antibody Market Share (%), By End-users, 2017-2031F
  • Figure 203. Middle East & Africa Custom Antibody Market Share (%), By Country, 2017-2031F
  • Figure 204. Saudi Arabia Custom Antibody Market, By Value, In USD Million, 2017-2031F
  • Figure 205. Saudi Arabia Custom Antibody Market Share (%), By Type, 2017-2031F
  • Figure 206. Saudi Arabia Custom Antibody Market Share (%), By Service, 2017-2031F
  • Figure 207. Saudi Arabia Custom Antibody Market Share (%), By Source, 2017-2031F
  • Figure 208. Saudi Arabia Custom Antibody Market Share (%), By Research Area, 2017-2031F
  • Figure 209. Saudi Arabia Custom Antibody Market Share (%), By Application, 2017-2031F
  • Figure 210. Saudi Arabia Custom Antibody Market Share (%), By End-users, 2017-2031F
  • Figure 211. UAE Custom Antibody Market, By Value, In USD Million, 2017-2031F
  • Figure 212. UAE Custom Antibody Market Share (%), By Type, 2017-2031F
  • Figure 213. UAE Custom Antibody Market Share (%), By Service, 2017-2031F
  • Figure 214. UAE Custom Antibody Market Share (%), By Source, 2017-2031F
  • Figure 215. UAE Custom Antibody Market Share (%), By Research Area, 2017-2031F
  • Figure 216. UAE Custom Antibody Market Share (%), By Application, 2017-2031F
  • Figure 217. UAE Custom Antibody Market Share (%), By End-users, 2017-2031F
  • Figure 218. South Africa Custom Antibody Market, By Value, In USD Million, 2017-2031F
  • Figure 219. South Africa Custom Antibody Market Share (%), By Type, 2017-2031F
  • Figure 220. South Africa Custom Antibody Market Share (%), By Service, 2017-2031F
  • Figure 221. South Africa Custom Antibody Market Share (%), By Source, 2017-2031F
  • Figure 222. South Africa Custom Antibody Market Share (%), By Research Area, 2017-2031F
  • Figure 223. South Africa Custom Antibody Market Share (%), By Application, 2017-2031F
  • Figure 224. South Africa Custom Antibody Market Share (%), By End-users, 2017-2031F
  • Figure 225. By Type Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 226. By Service Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 227. By Source Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 228. By Research Area Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 229. By Application Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 230. By End-users Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 231. By Region Map-Market Size (USD Million) & Growth Rate (%), 2023